Skip to main content

Articles

Page 6 of 14

  1. Cardiovascular disease (CVD) is an emerging contributor to national morbidity and mortality in Saudi Arabia. CVD risk prevention services are limited, particularly with an over-utilised public health sector an...

    Authors: Hadi A. Almansour, Nouf M. Aloudah, Tariq M. Alhawassi, Betty Chaar, Ines Krass and Bandana Saini
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:42
    Content type: Research Published on:

  2. The implementation of pharmaceutical services in hospitals contributes to the appropriate use of medicines and patient safety. However, the relationship of implementation with the legal framework and organizat...

    Authors: Laura C. Vargas López, Fela Viso Gurovich, Anahí Dreser Mansilla, Veronika J. Wirtz and Michael R. Reich
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:41
    Content type: Research Published on:

  3. Over the last year, the dangerous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread rapidly around the world. Malaysia has not been excluded from this COVID-19 pandemic. The resurgence of...

    Authors: Ching Siang Tan, Saim Lokman, Yao Rao, Szu Hua Kok and Long Chiau Ming
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:40
    Content type: Commentary Published on:

  4. Proper hand hygiene using alcohol-based handrub (ABHR) is an effective preventive approach for the current Coronavirus Disease 2019 (COVID-19) pandemic and other infections. World Health Organization recommend...

    Authors: Muluken Nigatu Selam, Regasa Bayisa, Andualem Ababu, Mahdi Abdella, Edessa Diriba, Minychel Wale and Assefa Mulu Baye
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:39
    Content type: Research Published on:

  5. Since the WHO announced that Covid-19 had become a global pandemic, online pharmacies have emerged as an extremely popular way to purchase medication due to the quarantine measures introduced by numerous count...

    Authors: Ammar Abdulrahman Jairoun, Sabaa Saleh Al-Hemyari, Naseem Mohammed Abdulla, Faris El-Dahiyat, Maimona Jairoun, Saleh Karamah AL-Tamimi and Zaheer-Ud-Din Babar
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:38
    Content type: Research Published on:

    The Correction to this article has been published in Journal of Pharmaceutical Policy and Practice 2021 14:44

  6. We considered the extent of the contribution of publicly funded research to the late-stage clinical development of pharmaceuticals and medicinal products, based on the European Commission (EC) FP7 research fun...

    Authors: L. Schmidt, O. Sehic and C. Wild
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:37
    Content type: Research Published on:

  7. Drug-related problems (DRPs) can occur at any stages of medication use processes, and a single drug could be associated with multiple DRPs. Once happened, it adversely affects health outcomes. In Ethiopia, eva...

    Authors: Fuad Adem, Jemal Abdela, Dumessa Edessa, Bisrat Hagos, Abraham Nigussie and Mohammed A. Mohammed
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:36
    Content type: Review Published on:

  8. Hyperglycemia is an undisputed epidemiological risk factor for microvascular complications in both type 1 and type 2 diabetes, integral in their causal pathways. Importantly, interventions that reduce the hype...

    Authors: Darren K. McGuire, Silvio E. Inzucchi, Odd Erik Johansen, Julio Rosenstock, Jyothis T. George and Nikolaus Marx
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:35
    Content type: Commentary Published on:

  9. In Nigeria, there is a prevalence of aversive life circumstances that frequently assail the mental health and well-being of the citizens, mitigating the impact of which necessitates the institution of psychoth...

    Authors: Adeboye Olakunle Bamgboye, Ibrahim Adebayo Hassan, Yusuff Adebayo Adebisi, Rachael Oluwatoyosi Farayola and Theogene Uwizeyimana
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:34
    Content type: Commentary Published on:

  12. Drug use evaluation is a structured, methodological, and criteria-based drug assessment system that helps to evaluate the actual trend of drug use in a particular setting. If drug prescription practices are in...

    Authors: Bereket Bahiru Tefera, Melese Getachew and Bekalu Kebede
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:31
    Content type: Review Published on:

  13. Advanced therapy medicinal products (ATMPs) represent an important cornerstone for innovation in healthcare. However, uncertainty on the value, the high average cost per patient and their one-shot nature has r...

    Authors: Virginia Ronco, Myriam Dilecce, Elena Lanati, Pier Luigi Canonico and Claudio Jommi
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:30
    Content type: Research Published on:

  14. Insufficient access to quality, safe, efficacious and affordable medical products in Africa has posed a significant challenge to public health for decades. In part, this is attributed to weak or absent policie...

    Authors: Bakani Mark Ncube, Admire Dube and Kim Ward
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:29
    Content type: Commentary Published on:

  15. Monitoring adverse drug reactions is a vital issue to ensure drug safety and to protect the general public from medication-related harmful effects. In order to properly monitor drug safety, a regulatory system...

    Authors: Zuzaan Zulzaga, Erdenetuya Myagmarsuren, Herman J. Woerdenbag and Eugene P. van Puijenbroek
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:15
    Content type: Commentary Published on:

  16. Measuring access to medicines has often been limited to assessing availability and affordability, while little is known regarding other dimensions of access including geographical accessibility. Our study aims...

    Authors: Cindrel Tharumia Jagadeesan and Veronika J. Wirtz
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:28
    Content type: Review Published on:

  17. Self-care is one of the growing tasks of community pharmacy professionals. They are highly engaged in consultations in response to specific drug request (product-based presentation) or symptoms clients describ...

    Authors: Dawit Wondimsigegn, Berhanemeskel Woldegerima and Asefa Adimasu Taddese
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:26
    Content type: Research Published on:

  18. Increasingly, there has been recognition that siloed approaches focusing mainly on human health are ineffective for global antimicrobial resistance (AMR) containment efforts. The inherent complexities of AMR c...

    Authors: Mohan P. Joshi, Tamara Hafner, Gloria Twesigye, Antoine Ndiaye, Reuben Kiggundu, Negussu Mekonnen, Ndinda Kusu, Safoura Berthé, Edgar Peter Lusaya, Alphonse Acho, Robert Tuala Tuala, Ayasha Siddiqua, Henri Kaboré, Soukeyna Sadiya Aidara and Javier Guzman
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:27
    Content type: Research Published on:

  19. The COVID-19 pandemic has further strengthened the need for pharmacists to uptake non-traditional roles. Pharmacy practice in Saudi Arabia is emerging in recent years with greater policy emphasis on pharmacist...

    Authors: Eeman Mohammed, Saval Khanal, Zahraa Jalal, Ejaz Cheema, Mohammed H. Abutaleb and Vibhu Paudyal
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:25
    Content type: Research Published on:

  20. Minor ailments are defined as common, self-limiting, or uncomplicated conditions that may be diagnosed and managed without a medical intervention. Previous studies reported that pharmacists were able to help p...

    Authors: Mei Mei Tew, Ernieda Hatah, Faiz Arif, Muhammad Aqiff Abdul Wahid, Mohd Makmor-Bakry and Khairul Nizam Abdul Maulad
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:24
    Content type: Research Published on:

  21. The sustainable development goals were launched by the United Nations in 2015. Its fifth goal was describing the achievement of universal health coverage by 2030. This goal reaffirms the importance of investin...

    Authors: Banan Abdulrzaq Mukhalalati, Meram Mohamed Mahmoud Elsayed Ibrahim, Majdoleen Omar Al Alawneh, Ahmed Awaisu, Ian Bates and Lina Bader
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:22
    Content type: Research Published on:

  22. Achieving universal health coverage will require robust private sector engagement; however, as many low- and middle-income countries launch prepayment schemes to achieve universal health coverage, few are cove...

    Authors: Martha Embrey, Romuald Mbwasi, Elizabeth Shekalaghe, Jafary Liana, Suleiman Kimatta, Gasto Ignace, Angel Dillip and Tamara Hafner
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:21
    Content type: Research Published on:

  23. Inventory management is the heart of the supply system in improving availability of medicines, reducing the cost, and improving patient care quality. However, in the government facilities’ supply system, inven...

    Authors: Oliyad Kebede and Gizachew Tilahun
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:20
    Content type: Research Published on:

  24. Clostridium difficile infection (CDI) is responsible for 15–25% cases of health-care-associated diarrhea. The CDI treatment algorithm used at our hospital is adapted from the Infectious Diseases Society of Americ...

    Authors: Ali Elbeddini and Rachel Gerochi
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:19
    Content type: Research Published on:

  26. To strengthen medicines management capacity, including supply chain management, at public sector health facilities in Uganda, the Ministry of Health introduced a multipronged supervision, performance assessmen...

    Authors: Denis Okidi Ladwar, Moses Nixon Sembatya, Nancy Miriam Amony, Morries Seru, Dennis Ross-Degnan, Laura Garabedian and Birna Trap
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:14
    Content type: Research Published on:

  27. Emergency department (ED) visits for high blood pressure are on the rise. Yet the majority of these patients are discharged home after their ED evaluation, particularly those who present following an elevated ...

    Authors: Ivona Mostarac and Clare L. Atzema
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:13
    Content type: Research Published on:

  28. The 4th PPRI Conference, held in Vienna in October 2019, addressed issues related to equitable and affordable access to medicines. A multi-stakeholder audience from around the globe discussed solutions and bes...

    Authors: Sabine Vogler, Nina Zimmermann, Zaheer-Ud-Din Babar, Reinhard Busse, Jaime Espin, Aukje K. Mantel-Teeuwisse, Dimitra Panteli, Fatima Suleman and Veronika J. Wirtz
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:18
    Content type: Commentary Published on:

  29. European countries face fiscal pressure regarding the long-term sustainability of their healthcare system due to increasing levels of public health expenditures and mounting demographic pressures. The promotio...

    Authors: Lisa Aufegger, Celine Yanar, Ara Darzi and Colin Bicknell
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:11
    Content type: Research Published on:

  30. The COVID-19 pandemic has resulted in massive disruptions in global supply chains. Nigeria is particularly vulnerable with respect to pharmaceuticals since there is reduced local production and about 70% of th...

    Authors: Edward Faiva, Hashim Talib Hashim, Mustafa Ahmed Ramadhan, Shingin Kovona Musa, John Bchara, Yahya Dheyaa Tuama, Yusuff Adebayo Adebisi, Mustafa Hayder Kadhim, Mohammad Yasir Essar, Shoaib Ahmad and Don Eliseo Lucero-Prisno III
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:17
    Content type: Commentary Published on:

  31. Well-functioning national regulatory authorities (NRAs) ensure access to safe, effective, quality-assured, and affordable medical products. However, the benefits of their work are often unseen and difficult to...

    Authors: Gloria Twesigye, Tamara Hafner and Javier Guzman
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:16
    Content type: Commentary Published on:

  32. COVID-19 is a threat to health systems around the world and Rwanda is not an exception. The impact of the pandemic is far-reaching and access to health commodities is not spared. Proper drug supply is critical...

    Authors: Theogene Uwizeyimana, Hashim Talib Hashim, Jean Damascene Kabakambira, Jean Claude Mujyarugamba, Jackson Dushime, Blaise Ntacyabukura, Remy Ndayizeye, Yusuff Adebayo Adebisi and Don Eliseo Lucero-Prisno III
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:12
    Content type: Commentary Published on:

  33. The incidence of preventable adverse drug events (ADE) is approximately one medication error per patient per hospital-day. A quality medication reconciliation (MedRec) process is a crucial intervention used to...

    Authors: Ali Elbeddini, Sarah Almasalkhi, Thulasika Prabaharan, Cindy Tran, Mohamed Gazarin and Ahmed Elshahawi
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:10
    Content type: Research Published on:

  34. Antimicrobial agents are among the most commonly prescribed drugs in pregnancy due to the increased susceptibility to infections during pregnancy. Antimicrobials can contribute to different maternal complicati...

    Authors: Mohamed A. Baraka, Lina Hussain AlLehaibi, Hind Nasser AlSuwaidan, Duaa Alsulaiman, Md. Ashraful Islam, Badriyah Shadid Alotaibi, Amany Alboghdadly, Ali H. Homoud, Fuad H. Al-Ghamdi, Mastour S. Al Ghamdi and Zaheer-Ud-Din Babar
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:9
    Content type: Research Published on:

  35. Research has shown that there is an increase in the global prevalence of asthma. Pharmacists are well positioned to screen and refer patients for better management of asthma. This study aimed to evaluate commu...

    Authors: Sanah Hasan, Lujain Al Oum and Nageeb AbdulGalil Hassan
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:8
    Content type: Research Published on:

  36. The pharmaceutical technology unit of the Geneva University Hospitals played a significant role in the fight against COVID-19 through four different missions: (1) providing enough hydroalcoholic solution at th...

    Authors: Alexandra Garnier, Ludivine Falaschi, Pascal Bonnabry and Lucie Bouchoud
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:7
    Content type: Letter to the editor Published on:

  38. Spontaneous reporting of adverse drug reactions (ADRs) is a method of monitoring the safety of drugs and is the basic strategy for the post-marketing surveillance of the suspected drugs. Despite its importance...

    Authors: Rabia Hussain, Mohamed Azmi Hassali, Furqan Hashmi and Tayyaba Akram
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:5
    Content type: Research Published on:

  39. Changing demographics across the UK has led to general practitioners (GPs) managing increasing numbers of older patients with multi-morbidity and resultant polypharmacy. Through government led initiatives with...

    Authors: Nadia Farhanah Syafhan, Sayer Al Azzam, Steven D. Williams, Wendy Wilson, Jayne Brady, Peter Lawrence, Mark McCrudden, Mustafa Ahmed, Michael G. Scott, Glenda Fleming, Anita Hogg, Claire Scullin, Robert Horne, Harblas Ahir and James C. McElnay
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:4
    Content type: Research Published on:

  40. Drug repurposing (i.e., finding novel uses for existing drugs) is essential for maximizing medicines’ therapeutic utility, but obtaining regulatory approval for new indications is costly. Policymakers have the...

    Authors: Babak Sahragardjoonegani, Reed F. Beall, Aaron S. Kesselheim and Aidan Hollis
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:3
    Content type: Research Published on:

  41. Acute bronchiolitis is the leading cause of hospitalization in the pediatric population. The inappropriate prescription of antibiotics in acute bronchiolitis is associated with bacterial resistance, higher cos...

    Authors: Jefferson Antonio Buendía and John Edwin Feliciano-Alfonso
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:2
    Content type: Research Published on:

  42. The coronavirus disease 19 (COVID-19) pandemic is putting a huge strain on healthcare systems and is a turning point for the beginning of a global health crisis of an unprecedented condition. As such, the prov...

    Authors: Gemmechu Hasen, Rashed Edris, Gadisa Chala, Yesuneh Tefera, Hawi Hussen, Tamirat Tekassa and Sultan Suleman
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:1
    Content type: Commentary Published on:

  43. When the first wave of COVID-19 hit in March 2020, health care professionals across Canada were challenged to quickly and efficiently adapt to change their work practices in these unprecedented times. Pharmacy...

    Authors: Ali Elbeddini, Amy Botross, Rachel Gerochi, Mohamed Gazarin and Ahmed Elshahawi
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:76
    Content type: Commentary Published on:

  44. The digitalization of health and medicine and the growing availability of electronic health records (EHRs) has encouraged healthcare professionals and clinical researchers to adopt cutting-edge methodologies i...

    Authors: Carlos Del Rio-Bermudez, Ignacio H. Medrano, Laura Yebes and Jose Luis Poveda
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:75
    Content type: Commentary Published on:

  45. In Lebanon, difficulties in accessing medications are due to two main barriers, mainly: high cost and the lack of medication safety, related to poor-quality (irrational) prescription and use. The objective of ...

    Authors: Aline Hajj, Hala Sacre, Souheil Hallit, Rony M. Zeenny, Georges Sili and Pascale Salameh
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:70
    Content type: Short report Published on:

  46. The coronavirus disease 19 (COVID-19) is rapidly spreading across the world. Pharmacy services play a vital role in public health in preventing and containing the COVID-19 pandemic. All over the world, especia...

    Authors: Kashif Hussain, Gul Ambreen, Mehreen Muzammil, Syed Shamim Raza and Umer Ali
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:74
    Content type: Commentary Published on:

  47. Smoking cessation pharmacotherapies (SCPs) have been established as cost-effective for the treatment of tobacco use disorder across a variety of settings. In Jordan, a resource-constrained country where smokin...

    Authors: Saba Madae’en, Nour Obeidat and Mohammad Adeinat
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:65
    Content type: Policy analysis Published on:

  49. Canada has been home to comparatively extreme developments in prescription opioid (PO) availability and related harms (e.g. morbidity, mortality) post-2000. Following persistent pan-Canadian increases in PO us...

    Authors: Wayne Jones, Lenka Vojtila, Paul Kurdyak and Benedikt Fischer
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:68
    Content type: Short report Published on:

  50. The declaration of COVID-19 a pandemic by the World Health Organization on 11 March 2020 marked the beginning of a global health crisis of an unprecedented nature and scale. The approach taken by countries acr...

    Authors: Diane Ashiru-Oredope, Amy Hai Yan Chan, Omotayo Olaoye, Victoria Rutter and Zaheer-Ud-Din Babar
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:72
    Content type: Research Published on:
Submit manuscript

Follow

Annual Journal Metrics

Journal of Pharmaceutical Policy and Practice

ISSN: 2052-3211

Contact us